发明名称 ATTENUATION OF REPERFUSION INJURY
摘要 Compositions for and methods of attenuating and/or preventing ischemia-reperfusion injury (IRI) are provided. One method comprises administering to a patient in need thereof an agent that binds phosphatidylserine (PS) located on cell surfaces, i.e., PS binding agent. Another method comprises administering to an organ transplant recipient a therapeutic composition comprising a PS binding agent. A method of preventing IRI to cells is also provided. The method comprises adding a PS-binding agent to a therapeutic composition used to treat the cells. Further provided is a method of protecting an organ or a tissue susceptible to IRI. The method comprises contacting the organ or tissue with a PS-binding agent. Such an agent may, for example, attenuate IRI in patients with stroke or myocardial infarction, or following surgical operations. PS-binding agents include modified annexin proteins, antibodies against PS molecules, and other anti-PS molecules.
申请公布号 WO2008008561(A3) 申请公布日期 2008.07.31
申请号 WO2007US66561 申请日期 2007.04.12
申请人 ALAVITA PHARMACEUTICALS, INC.;ALLISON, ANTHONY 发明人 ALLISON, ANTHONY
分类号 A61K38/00 主分类号 A61K38/00
代理机构 代理人
主权项
地址